Scanxiety isn’t just about CTs, MRIs, or PET scans. It’s also about waiting for biomarker blood tests, ctDNA monitoring, or tumor markers. It’s the unease that creeps in days before the appointment, the tension of watching the doctor’s face as they read your chart, the overwhelming silence that follows when results are pending.
Scanxiety: A Silent Struggle Shared by Many Patients and Caregivers Read More »
The American Society of Clinical Oncology (ASCO) 2025 annual meeting, held from May 30 to June 3, 2025, featured significant clinical developments across multiple cancer treatment modalities, with particular attention to antibody-drug conjugates (ADCs), CAR-T cell therapies, and immuno-oncology agents.
ASCO 2025 Highlights: Key Clinical Developments and Regulatory Updates Read More »
This comprehensive guide will walk you through the essential steps to take immediately following your diagnosis, helping you move from initial shock to informed action while maintaining hope and agency throughout your cancer journey.
What to Expect After a Cancer Diagnosis Read More »
Some experts champion soy for its potential protective effects, while others raise concerns about its influence on hormone-related cancers, especially breast cancer. This post explores both perspectives, reviews the latest research, and offers practical nutrition tips for cancer patients considering soy in their diets.
Nutrition Tips for Cancer Patients: The Soybean Debate Read More »
The past two months have brought exciting progress in cancer care, with new therapies offering hope for better outcomes and fewer side effects. Below, we break down the latest updates in simple terms, focusing on how these advances might help patients and families navigate treatment decisions.
Cancer Treatment Breakthrough Updates – April / May 2025 Read More »
PD-1/PD-L1 inhibitors have transformed cancer care, but their immune-activating mechanisms often lead to diverse side effects requiring tailored management. By categorizing these adverse events and pairing them with evidence-based strategies, patients and clinicians can better navigate treatment challenges. Below, we explore common and rare side effects, their clinical presentations, and practical management approaches, enriched with real-world patient experiences.
Managing PD-1/PD-L1 Immunotherapy Side Effects: Strategies and Patient Insights Read More »
This post explores how docetaxel works, its effectiveness in treating various cancers, its common side effects, and practical ways to manage them.
Understanding Docetaxel: Effectiveness and Managing Side Effects in Cancer Treatment Read More »
Key advancements across cancer types from AACR 2025 highlight progress in targeted therapies, immunotherapies, and innovative technologies, with several treatments entering late-stage development or regulatory review
Treatment Progress: Key Findings from AACR 2025 Read More »
This comprehensive guide explores the key differences between these approaches and addresses concerns about long-term survival for stage 4 cancer patients receiving palliative care.
Cancer prognosis is a complex topic that patients and caregivers often struggle to interpret correctly. When faced with a cancer diagnosis, many turn to the internet for information about survival and treatment outcomes, but this can lead to misunderstandings and unnecessary anxiety. This blog post aims to clarify common misconceptions about cancer prognosis, highlight issues with online prognosis data, provide guidance on understanding prognostic information more accurately, and share current survival statistics for common cancer types.
Understanding Cancer Prognosis: Beyond Five-Year Survival Rates Read More »
